A study by an American research team has shown that cigarettes sold in the United States, marketed as tobacco-free, contain a synthetic nicotine analog called 6-methylnicotine and high levels of CBD, highlighting new regulatory loopholes.
In a recent study, American experts examined Choice™ brand cigarettes sold as tobacco-free in U.S. online and physical stores. Analysis performed using gas chromatography-mass spectrometry and ultra-performance liquid chromatography-mass spectrometry confirmed that the products do not contain significant amounts of traditional tobacco or nicotine; however, they were found to contain the synthetic nicotine analog 6-methylnicotine in quantities of approximately 455–484 µg per cigarette. Additionally, the study showed that the cigarettes contain significant amounts of cannabidiol (CBD), suggesting that the plant-based filler is derived from hemp.
Researchers pointed out that products containing such synthetic nicotine analogs may be able to circumvent existing tobacco and nicotine regulations. Since 6-methylnicotine may be more potent than traditional nicotine, experts are calling for urgent legislative and regulatory action to prevent the bypassing of smoking bans, taxation, age restrictions, and flavor bans.
In brief
- A synthetic analog called 6-methylnicotine was found in cigarettes sold as tobacco-free on the U.S. market.
- The products also contain high concentrations of CBD, indicating the presence of hemp-based filler.
- The presence of 6-methylnicotine threatens existing tobacco and nicotine regulations, as well as taxation and age-limit requirements.
Source: Europe PMC (doi.org)
This summary was generated by artificial intelligence based on the original article.